From the point of diagnosis through the time long after treatment ends, technology is reshaping what it means to navigate cancer. What once felt clinical and distant is now becoming connected and compassionate.
Across the world, scientists are finding creative ways to weave digital tools into every step of the cancer journey. Smartphones, wearable sensors, telehealth platforms, and integrative apps are doing more than making care convenient, they’re amplifying empathy. They help patients feel seen between visits, caregivers feel supported in their roles, and healthcare providers focus on what matters most.
In this feature, we highlight a selection of recent studies that show how, when innovative technology meets empathy and science, care becomes more personal, proactive, and empowering.
The AI‑STREAM study offers a glimpse of a future in which radiologists don’t have to shoulder the task of mammography screening alone. In a large prospective study across 6 hospitals in South Korea, more than 24,000 mammograms from women aged 40 years and older were interpreted with and without AI assistance.
The difference was striking, with AI support improving the cancer detection rate by almost 14%, without any meaningful rise in recall rates. That means the technology caught more true positives without creating additional anxiety or false alarms.
For healthcare providers, the study demonstrates how AI can serve as a safety net rather than a threat, helping humans focus on what matters most. And for patients, it signals that asking whether their screening center uses AI assistance could soon be as routine as asking about 3D imaging.
Source: Chang Y-W, Ryu JK, An JK, et al. Artificial intelligence for breast cancer screening in mammography (AI-STREAM): preliminary analysis of a prospective multicenter cohort study. Nat Commun. 2025;16:2248.
Reading a prostate MRI can be an interpretive art, with some lesions appearing clear and others subtle enough to challenge even experienced eyes. Experts behind a multinational study have found that AI can tighten those margins.
Radiologists across multiple centers reviewed MRI scans with and without algorithmic guidance. When supported by AI, their diagnostic accuracy rose from 0.882 to 0.916, and the improvement was most pronounced among less experienced readers.
This means patients benefit from more consistent, high‑quality interpretation regardless of who reads their scan. Rest assured that AI isn’t replacing the radiologist’s judgment in this context—it’s simply sharpening it.
Source: Twilt JJ, Saha A, Bosma JS, et al. AI-assisted vs unassisted identification of prostate cancer in magnetic resonance images. JAMA Netw Open. 2025;8:e2515672.
Despite decades of evidence showing that early detection saves lives, lung cancer screening remains dramatically underused. Researchers behind the mPATH‑Lung randomized trial wondered if the answer lay not in new machines but in smarter communication strategies.
More than 1300 adults who met national screening criteria were assigned to either usual care or a digital outreach program that combined a short educational video, a decision‑making aid, and an instant scheduling option. The results were encouraging, with 24.5% of those in the digital arm completing a screening CT within 16 weeks compared with 17% in the control group.
These results are a reminder that small, thoughtful interventions can create big movements when technology meets behavioral science.
Source: Miller DP, Snavely AC, Dharod A, et al. A direct-to-patient digital health program for lung cancer screening. JAMA. 2025;334:1807-1815.
Cancer treatment doesn’t pause between visits, and symptoms often escalate when no one is watching. That reality motivated one of the largest real‑world studies of electronic patient‑reported outcomes (ePROs) to date.
Nearly 6000 patients receiving systemic therapy were tracked, with about 1400 participating in weekly digital symptom check‑ins. Compared with their peers, ePRO participants experienced up to a 19% reduction in hospitalizations within 3 months. Nurses intervened earlier, and clinicians reported catching complications before they became crises.
The technology itself is simple (text messages or app prompts), but the effect is profound; patients feel seen and supported even at home, and health systems save lives by listening sooner.
Source: Rocque GB, Franks JA, Deng L, et al. Remote symptom monitoring with electronic patient-reported outcomes in clinical cancer populations. JAMA Netw Open. 2025;8:e259852.
Cancer fatigue can feel like a fog that refuses to lift—and traditional approaches often fall short. That’s why researchers at Memorial Sloan Kettering and Rutgers University explored whether a digital integrative medicine program could bring relief to patients receiving active treatment.
In the 12-week trial, 200 participants joined “IM@Home,” a live, virtual program offering weekly mind-body classes, gentle movement, and guided relaxation via Zoom. Others received standard care with access to prerecorded wellness videos. The results were striking; those in the live program reported less fatigue, reduced anxiety and depression, and even fewer emergency department visits and hospital stays.
The takeaway is simple but profound—wellness doesn’t have to wait for remission or rely on in-person visits. Structured, interactive online programs can bring healing tools right into the living room, helping patients rebuild strength, rest more deeply, and reconnect with a sense of control.
Source: Mao JJ, Bryl K, Gillespie EF, et al. Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment. NPJ Digit Med. 2025;8:29.
Stress, worry, and sleepless nights often shadow the cancer experience. In Germany, psychologist Dr Jürgen Barth and colleagues wondered whether guided relaxation through a smartphone app could make a measurable difference.
Their study, called CanRelax 2, enrolled more than 200 adults with cancer who reported high distress levels. Half used the app for 10 weeks, practicing mindfulness and breathing exercises; the others waited on a control list.
The results? Those using CanRelax felt noticeably less anxious and depressed, and they described greater overall well-being. Many said the app became a daily ritual, a few minutes of calm that helped them face appointments, treatments, and uncertainty with clearer minds.
Technology can’t erase fear, but this study shows it can offer something powerful: accessible, stigma-free mental health support that fits into everyday life. With just a phone and a little time, patients can reclaim a sense of peace, one breath at a time.
Source: Barth J, Schläpfer S, Schneider F, et al. Mobile health intervention CanRelax reduces distress in people with cancer in a randomized controlled trial. NPJ Digit Med. 2025;8:269.
In Japan, a team led by Dr Yuki Kikawa wanted to find out whether technology could help patients feel better supported during tough treatment regimens. They designed a clinical trial in which people receiving trastuzumab deruxtecan (T-DXd) for metastatic HER2-positive breast cancer used a smartphone app to record weekly symptoms and daily vital signs (eg, temperature and oxygen levels) from the comfort of their home. Whenever a reading looked concerning, a nurse reached out to the patient in question.
After 24 weeks, patients using the app reported feeling stronger, more engaged, and less fatigued than those receiving standard care. Their global health scores improved, as did their day-to-day functioning. The monitoring didn’t change survival, but it gave people real-time reassurance that someone was keeping an eye on them.
For patients, this study highlights the power of connection. Tracking symptoms and sharing them with a care team can help prevent small issues from becoming big ones—and ease the anxiety of “going it alone” between visits.
Source: Kikawa Y, Uemura Y, Taira T, et al. Electronic patient-reported outcomes with vital sign monitoring during trastuzumab deruxtecan therapy: the PRO-DUCE randomized clinical trial. JAMA Netw Open. 2025;8:e2527403.
Caring for a loved one at home during advanced illness can be both rewarding and overwhelming. Researchers in China asked whether a simple educational app could help families feel more prepared—and help patients feel better.
In this single-center study, caregivers of people with incurable cancer received an app filled with practical modules about managing pain and nausea, preventing pressure sores, understanding medications, and communicating with healthcare providers. Two months later, patients whose caregivers used the app had higher quality-of-life scores and less anxiety than those receiving standard information alone.
The lesson is clear: knowledge is care, and digital education at one’s fingertips gives families the confidence to handle challenges compassionately and effectively, ensuring patients remain comfortable and supported at home.
Source: Yu Y, Xue H, Suo C, et al. Palliative care educational app for family caregivers of homebound patients with incurable cancer: a single-center randomized trial. Ann Intern Med. 2025;178:1737-1751.
From AI-enhanced imaging to virtual mindfulness classes, technology is no longer a sidebar in cancer care—it’s part of the story.
These studies remind us that when innovation meets empathy, care becomes more human. Technology can calm anxiety before a scan, help families breathe easier at home, and make every interaction (from screening through survivorship) a little stronger, smarter, and more supported.
For patients, caregivers, and healthcare providers alike, the message is simple: the future of cancer care isn’t just about extending life—it’s about enriching it, every step of the way.
Portions of this article were written with AI assistance.
Keep up to date with the latest news from us via social networks:
To sign up for our print publication or e-newsletter, please enter your contact information below.
